Heart disorder

Related records

Broader conditions (4)

• Cardiovascular disorder
• Disease
• Disease by body system or component
• Human disease

Narrower conditions (721)

• 22q11.2 deletion syndrome
• 46,XY complete gonadal dysgenesis
• 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
• 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome
• 46,XY sex reversal 1
• 46,XY sex reversal 10
• 46,XY sex reversal 11
• 46,XY sex reversal 2
• 46,XY sex reversal 3
• 46,XY sex reversal 4
• 46,XY sex reversal 5
• 46,XY sex reversal 6
• 46,XY sex reversal 7
• 46,XY sex reversal 9
• 6q25.1 microdeletion syndrome
• 8q24.3 microdeletion syndrome
• AA amyloidosis
• Abnormal number of coronary ostia
• Accessory tricuspid valve tissue
• ACTC1-related distal arthrogryposis with congenital heart disease

Trials (2,961)

• 'MInimalist' or 'MOre Complete' Strategies for Revascularization in Octogenarians
• "Reversibility of Cardiovascular Injury With CPAP Use: Mechanisms Involved"
• "SVEAT" Chest Pain Scoring System
• 10-Years Follow-up of the EXAMINATION Trial
• 123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation
• 2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).
• 24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
• 3D & Speckle Tracking Together as a Marker for Early Outcome in Cardiac Surgery
• 4 Cities for Assessing CAlcification PRognostic Impact After TAVI
• 4-electrode ECG (DigitalCardio®) vs Standard 10-electrode ECG: Evaluating Ease of Use and Recording Quality
• A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)
• A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)
• A Clinical Trial in Higher Risk Geriatric Patients Undergoing OHSP
• A Clinical Trial of IntensiVE Dialysis
• A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters
• A Comparative Study of Subjects Past Their Final Follow-ON Visit
• A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Early Post-transplantation
• A Comparison of Computerised Versus Interviewer-administered Approach for Assessing Health-related Quality of Life
• A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction
• A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)

Approved drugs (4)

• Denopamine
• Ibopamine
• Inamrinone lactate
• Perflubutane

Drugs in development (117)

• Acebutolol Phase 2
• Adenosine triphosphate Phase 2
• Adenosine triphosphate disodium Phase 2
• Alferminogene tadenovec Phase 3
• Allopurinol Phase 3
• Amiodarone Phase 3
• Amlodipine Phase 2
• Angiotensin II Phase 1
• Anti-inhibitor coagulant complex Phase 2
• Ascorbic acid Phase 2
• Aspirin Phase 3
• Atenolol Phase 3
• Azithromycin Phase 3
• Beperminogene perplasmid Phase 3
• Beta carotene Phase 2
• Bivalirudin Phase 3
• Calcium Phase 2
• Candesartan Phase 3
• Captopril Phase 2
• Cenderitide Phase 2

Other linked drugs (18)

• Amlodipine maleate
• Arginine
• Atorvastatin
• Choriogonadotropin alfa
• Decitabine
• Deferiprone
• Deferoxamine
• Deferoxamine hydrochloride
• Ezetimibe
• Ganirelix acetate
• Gonadotropin, chorionic
• Hydrochlorothiazide
• Metformin
• Pravastatin
• Progesterone
• Rosiglitazone
• Simvastatin
• Testosterone